全文获取类型
| 收费全文 | 132篇 |
| 免费 | 41篇 |
专业分类
| 10篇 | |
| 综合类 | 6篇 |
| 水产渔业 | 2篇 |
| 畜牧兽医 | 152篇 |
| 园艺 | 2篇 |
| 植物保护 | 1篇 |
出版年
| 2021年 | 1篇 |
| 2020年 | 3篇 |
| 2019年 | 3篇 |
| 2018年 | 12篇 |
| 2017年 | 15篇 |
| 2016年 | 8篇 |
| 2015年 | 7篇 |
| 2014年 | 15篇 |
| 2013年 | 13篇 |
| 2012年 | 13篇 |
| 2011年 | 15篇 |
| 2010年 | 17篇 |
| 2009年 | 7篇 |
| 2008年 | 4篇 |
| 2007年 | 2篇 |
| 2006年 | 3篇 |
| 2005年 | 1篇 |
| 2004年 | 1篇 |
| 2003年 | 3篇 |
| 2002年 | 1篇 |
| 1999年 | 4篇 |
| 1998年 | 3篇 |
| 1997年 | 6篇 |
| 1996年 | 1篇 |
| 1995年 | 1篇 |
| 1994年 | 1篇 |
| 1992年 | 1篇 |
| 1991年 | 1篇 |
| 1989年 | 1篇 |
| 1987年 | 1篇 |
| 1986年 | 3篇 |
| 1983年 | 2篇 |
| 1981年 | 1篇 |
| 1978年 | 1篇 |
| 1949年 | 1篇 |
| 1943年 | 1篇 |
排序方式： 共有173条查询结果，搜索用时 31 毫秒
91.
92.
AE Jackson 《Australian veterinary journal》2017,95(10):353-354
93.
AE Jackson 《Australian veterinary journal》2017,95(5):135-136
94.
Background – Terbinafine, an allylamine antifungal, is used in pulsatile dose regimens for superficial mycoses in human medicine. Objectives – To compare the clinical efficacy of twice‐weekly versus once‐daily terbinafine administration to determine whether preliminary proof‐of‐concept evidence exists for pulsatile administration of terbinafine in the treatment of canine Malassezia dermatitis and to determine whether twice‐weekly treatment results in fewer clinical and owner‐perceived adverse events. Animals – Twenty client‐owned dogs with Malassezia dermatitis. Methods – In this randomized, single‐blinded clinical trial, dogs were randomly assigned to receive terbinafine (30 mg/kg) either once daily for 21 days (n = 10) or once daily on two consecutive days per week for six doses (n = 10). On day 0 and day 21, a mean yeast count was calculated from eight anatomical locations via adhesive tape‐strip cytology, clinical lesion scores were assigned to the same locations, and owners assessed pruritus using a visual analog scale. Results – There was no significant difference between treatment groups with respect to the reduction in mean yeast count (P = 0.343) and clinical lesion scores (P = 0.887). Pruritus measured by visual analog scale was significantly decreased in the twice‐weekly treatment group compared with the daily treatment group (P = 0.047). Seven of 20 dogs had a clinically measurable or owner‐reported adverse event during treatment that included gastrointestinal disturbances, excessive panting and elevated hepatic enzymes, with no significant difference noted between treatment groups. Conclusions and clinical importance – This pilot study indicates that twice‐weekly terbinafine administration may be an effective alternative treatment for canine Malassezia dermatitis and merits further investigation. 相似文献
95.
AE Jackson 《Australian veterinary journal》2012,90(5):155-156
Breech‐strike in Merinos in south‐eastern Australia · Risk factors for clinical mastitis in dairy cows · Tick (Ixodes holocyclus) envenomation in horses · Attitudes to and use of analgesia by Queensland veterinarians · Treatment of anoestrus in bitches · Risk of arboviruses following waterbird movement 相似文献
96.
97.
98.
99.
OBJECTIVE: To determine the efficacy of doxorubicin when used alone in inducing remission in cats with lymphosarcoma. DESIGN: Prospective multi-institutional study of naturally occurring disease. METHODS: Cases were accrued from veterinary institutions in Australia and New Zealand after obtaining consent from informed owners. Cats were treated with doxorubicin every 3 weeks for three treatments. If there was no response to the first dose of doxorubicin or if the cat relapsed during the doxorubicin regimen, the cat was withdrawn from the trial and either euthanased or treated with other agents. Age, breed, gender and anatomic site of the lymphosarcoma (multicentric, alimentary, mediastinal, extranodal) were recorded for each cat. Clinical remission was assessed before each treatment by physical examination, radiography, ultrasonography and computed tomography where appropriate. Complete remission was defined as the disappearance of all clinical signs and clinically detectable tumour. RESULTS: Twenty-one cases were accrued over a 2-year-period but only 19 were available for data analysis. Young Siamese cats were over-represented and all cats with mediastinal tumours were young Siamese. There was a significant difference between the mean ages of cats with mediastinal or multicentric lymphosarcoma (mean +/- SD: 3.5 +/- 3.0 and 4.3 +/- 2.6 years, respectively) and cats with alimentary or extranodal LSA (11.4 +/- 0.9 and 11.0 +/- 0.9 years, respectively). Of 19 cats treated with doxorubicin alone, 6 (32%) had complete remission, 6 (32%) had partial remission and 7 (36%) did not respond. CONCLUSIONS: The results suggest that doxorubicin cannot be recommended as a single agent for treatment of feline lymphosarcoma because of the rather poor remission rate achieved. 相似文献
100.